This message contains images. If you don't see images, click here to view.
Advertise in this news brief.




  Mobile version   RSS   Subscribe   Unsubscribe   Archive   Media Kit Oct. 23, 2013


 



Hormones in BRCA gene carriers 'explain cancer risk'
Medical News Today
A new study suggests that abnormal levels of female hormones in the bloodstream may be a reason why women with faulty BRCA1 and BRCA2 genes are more likely to develop breast and ovarian cancer over other cancers. Researchers from the Department of Women's Cancer at University College London (UCL) in the U.K. say their findings have already led to further research looking at new ways to prevent the cancers in women who are at higher risk.
   Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE  




Search tools wanting on many exchanges
The New York Times via NewsWatch
As he was trying to sign up for health insurance through Kentucky’s new online exchange this month, Kenny Wheeler hit a wall. Mr. Wheeler, an independent sales representative with a neuromuscular disorder, had succeeded where many in other states had failed, getting through a thicket of log-in pages. But when he tried to find out whether two health plans he liked would pay for his medications or let him keep his current doctors, he could not. He called one doctor on the spot, but the receptionist could not tell him whether the practice was in the new plan networks. Nor could Mr. Wheeler, 61, get quick answers from the insurers themselves. Exasperated, he put off completing his application.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Advertisement
SPONSORED CONTENT


New blood test can detect lung and prostate cancers
Fox News
A new blood test can help detect the presence of early-stage lung and prostate cancers — as well as any recurrences of these diseases. In a new study presented at the Anesthesiology 2013 annual meeting, researchers  found that an increased level of serum-free fatty acids and their metabolites in the bloodstream can help indicate the presence of lung cancer in the body. According to the study’s authors, such a test could be extremely beneficial for the detection and management of the disease.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


New white paper addresses the impact of the ACA on cancer care
A new, in-depth publication entitled How Health Reform Is Transforming U.S. Healthcare: Implications for Cancer Care examines the key provisions in the Patient Protection and Affordable Care Act (ACA) that impact cancer care. From the Physician Quality Reporting System’s aim to boost quality measures reporting to the potential for accountable care organizations to transform care delivery, this paper sheds light on these and other key ACA provisions impacting cancer care.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


PRODUCT SHOWCASE
  Special Offer for Readers of The CoC Brief — Practice Review
Are you concerned about diminishing reimbursements? Time to take action and give your practice a check up!
1) Take advantage of the complimentary Practice Analysis.
2) See how you can prepare for the Affordable care Act.
From production and reimbursement to coding and A/R, find out where you are and what you can do to take advantage of the changes in healthcare and to protect your practice.
 


Chemo-induced menopause symptoms similar to spontaneous
Medscape
Breast cancer patients who have chemotherapy-induced menopause have climacteric symptoms at rates similar to those of women who go through spontaneous menopause before their breast cancer diagnosis, a new study shows. "We were quite surprised when we looked at the results. I was certainly expecting to find that younger women who had chemotherapy-induced ovarian failure would have more severe symptoms," said Martha Hickey, MD, from the University of Melbourne in Australia.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Help us improve AJCC cancer staging resources!
ACS
The AJCC has commissioned a survey to solicit user feedback on the AJCC Cancer Staging Manual, Handbook, and Atlas. The AJCC will use this information to enhance current and future products.

After just 10 minutes of your time, all participants will be entered into a raffle for the chance to win one of 10 $100 American Express gift cards. Click HERE to take the survey.

Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Boost after whole breast radiation for ductal carcinoma in situ?
Clinical Oncology News
A Canadian study comparing the effects of additional (so-called boost) radiation with the tumor cavity in the treatment of patients with ductal carcinoma in situ (DCIS) demonstrated no advantage in the development of local recurrence from the addition of the boost radiation to the standard approach, which consists of breast-conserving surgery and radiation therapy.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


  FEATURED COMPANIES
Oncology OnTrack Supports Nurse Navigation
Oncology OnTrack is used to navigate patients with any cancer type from screening to diagnosis, treatment and survivorship, interfaces with other programs and supports accreditations.
EQUICARE CS - Cancer Navigation and Survivorship

EQUICARE CS provides all three facets of continuum of care services and has included information on their services in the Proprietary Material section of the Best Practices Repository section on the CoC website.


Watson arrives in medicine, first stop oncology and chemotherapy recommendations
iMedicalApps
IBM and MD Anderson recently announced the development of a prototype of a platform designed to provide treatment recommendations for and help guide the management of oncology patients. Oncology Expert Advisor will be available to oncologists affiliated with MD Anderson through both computers and mobile devices. The platform will take patient data, both that contained in discrete structured forms and in unstructured clinical notes, and match it up to match it up to clinical data, research protocols, treatment guidelines, and more to make a more personalized treatment recommendation.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


NAPBC education event — Lead Your Breast Program to Excellence
ACS
Plan today to attend the National Accreditation Program for Breast Centers (NAPBC) Lead Your Breast Program to Excellence Conference. This dynamic, two-day conference will include expert faculty who developed the standards. Hear how you can build quality programs into your multidisciplinary breast center by utilizing nationally recognized standards as your foundation. This two-day conference will be held Nov. 15–16 in Chicago. Last year’s program was sold out; don’t delay, registration is already filling up. Register TODAY!
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE


Nanotech system, cellular heating may improve treatment of ovarian cancer
R&D Magazine
The combination of heat, chemotherapeutic drugs, and an innovative delivery system based on nanotechnology may significantly improve the treatment of ovarian cancer while reducing side effects from toxic drugs, researchers at Oregon State University report in a new study. The findings, so far done only in a laboratory setting, show that this one-two punch of mild hyperthermia and chemotherapy can kill 95 percent of ovarian cancer cells, and scientists say they expect to improve on those results in continued research.
Share this article:   Share on FacebookTwitterShare on LinkedinE-mail article
READ MORE
Looking for similar articles? Search here, keyword OVARIAN CANCER.
 




The CoC Brief

Colby Horton, Vice President of Publishing, 469.420.2601
Download media kit

Samantha Emerson, Content Editor, 469.420.2669
Contribute news

Disclaimer: The CoC Brief is a digest of the most important news selected for the American College of Surgeons Commission on Cancer from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Commission on Cancer does not endorse any of the advertised products and services. Opinions expressed in the articles are those of the author and not of the American College of Surgeons and the Commission on Cancer.


Be sure to add us to your address book or safe sender list so our emails get to your inbox. Learn how.

This edition of The CoC Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here — it's free!

Recent issues

Oct. 23, 2013
Oct. 18, 2013
Oct. 16, 2013
Oct. 9, 2013






7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063